Regadenoson Injection, Solution
Product Images NDC 71288-201

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 71288-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regadenoson Carton (Reg Carton 03.2021 V2)

Packaging label for Regadenoson Injection 0.4 mg per 5 mL (0.08 mg per mL) single-dose pre-filled syringe by Meitheal Pharmaceuticals Inc. The label specifies intravenous use only and includes instructions for aseptic technique with illustrations. The packaging includes barcode, dosage, and usage warnings.*

FDA Label Image

Regadenoson Syringe (Reg Syringe V2)

Label for Regadenoson Injection 0.4 mg per 5 mL (0.08 mg per mL) in a 5 mL single-dose pre-filled syringe. The product is for intravenous use only and indicated for pharmacologic stress. It is manufactured for Meitheal Pharmaceuticals Inc., Chicago, IL, and made in China. The label includes the NDC 71288-201-85 and a barcode.*

FDA Label Image

Structural Formula (Reg05 0001 01)

Chemical structure of Regadenoson, an active ingredient shown along with a water molecule (H2O) in the molecular formula diagram.*

FDA Label Image

Logo (Reg05 0001 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.